NEXGEL, Inc. (NXGLW) revenue by segment

NXGLWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGL

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 6/3072% below fair value

$0.01+0.00 (0.00%)

Close on Oct 30, 2026Market cap $34.21MP/E –Yield –

NEXGEL, Inc. revenue by segment

Nexgel does not break out revenue by segment, region or product in the tagged data of its filings for this period type.